1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Imports
  5. Import of Heparin for Th…

Import of heparin for therapeutic use to Moldova: Growth in 2016

Compared to the previous year the indicator strongly climbed by 116.67%, refreshed numbers from United Nations Statistical Office present. The variable increased sharply by 7 kilogram, as it follows the tendency of the prior year when it rose by 50 percent. The overall changes for the previous 19 years attained a fall of 94.9%. Likewise, it has had a negative compound annual growth rate of 0.04 percent during the last 5 years with a marginal overall diminution since the start of time series. It averaged 55.16 kilogram from 1998 to 2016 and it reached its all-time high of 410 kilogram in 2003 and record low of 1 kilogram in 2004.

Import of heparin for therapeutic use to Moldova: Growth in 2016
Date Kilogram Variation
2016 13.00 116.67
2015 6.00 50
2014 4.00 -77.78
2013 18.00 12.5
2012 16.00 33.33
2011 12.00 -76.47
2010 51.00 2450
2009 2.00 -98.31
2008 118.00 31.11
2007 90.00 429.41

Related Statistics

Pharmaceutical Imports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales